SUPPLEMENTAL EXPERIMENTAL PROCEDURES

Ovariectomy and estradiol replacement
Sprague-Dawley rats were bilaterally ovariectomized (OVX) or sham-operated as described previously (Martínez de Morentin et al., 2014; Martinez de Morentin et al., 2015) . Estradiol treatment was carried out three weeks after surgery to ensure a total washout of endogenous ovarian hormones. OVX rats received a daily SC injection of estradiol (estradiol benzoate; 2 µg dissolved in 100 µL of sesame oil; both from Sigma;
St Louis, MO, USA) or vehicle (100 µL of sesame oil; control rats) during 3 days (Martínez de Morentin et al., 2014; Martinez de Morentin et al., 2015) .
Intracerebroventricular and nucleus-specific treatments
ICV cannulae were implanted under ketamine/xylazine anesthesia, as previously described (Nogueiras et al., 2007; López et al., 2008; López et al., 2010; Whittle et al., 2012; Martínez de Morentin et al., 2012; Imbernon et al., 2013; Martínez de Morentin et al., 2014; Contreras et al., 2014; Beiroa et al., 2014) . Animals were individually caged and allowed to recover for four days. For BMP8B acute experiments, animals were ICV treated with vehicle (5 µL of saline for rats and 2 µL of saline for mice) or BMP8B (5 µL of 4nM BMP8B for rats and 2 µL of 100 pM BMP8B for mice) (R&D Systems, Minneapolis, MN, USA); animals were treated at 09:00 AM (one hour after the light cycle had commenced). For the cold exposure experiments female rats (experiments were repeated twice and the number of animals per experimental group was 4-8 in each replicate, a representative experiment is shown) or mice (the number of animals per experimental group was 6-8) were housed in a climate chamber at 4ºC. BMP8B was ICV administered (at the above dose) after 10 hours and maintained the animals in a cold environment for a total 12 hours. For chronic treatments, BMP8B (0.1 pmol/day/rat) was delivered via a permanent 28-gauge stainless steel cannula (Plastics One, Roanoke, VA, USA) inserted bilaterally either in VMH or LHA, directed to the following stereotaxic coordinates: 2.8 mm posterior to bregma, ±0.6 mm lateral to midline and 10.1 mm ventral or 2.9 mm posterior to bregma, ±2.0 mm lateral to midline and 8.1 mm ventral, respectively (Imbernon et al., 2013; Contreras et al., 2014) . A catheter tube was connected from each infusion cannula to an osmotic minipump flow moderator (Model 1007D; Alzet Osmotic Pumps, Cupertino, CA, USA). These pumps had a flow rate of 0,5 µL/hour during 7 days of treatment. The osmotic minipumps were inserted in a subcutaneous pocket on the dorsal surface created using blunt dissection and the treatment was given during 7 days. The experiments were repeated twice and the number of animals per experimental group was 8 in each of replicate (total number of 16 animals per experimental group).
Stereotaxic microinjection of adenoviral and lentiviral vectors
Rats were placed in a stereotaxic frame (David Kopf Instruments; Tujunga, CA, USA) under ketamine-xylazine anesthesia. The VMH was targeted bilaterally using a 25-gauge needle (Hamilton; Reno, NV, USA). The injections were directed to the following stereotaxic coordinates for the VMH: 2.4/3.2 mm posterior to the bregma (two injections were performed in each VMH), ±0.6 mm lateral to midline and 10.1 mm ventral as previously reported (López et al., 2008; López et al., 2010; 
Energy expenditure, locomotor activity, respiratory quotient and nuclear magnetic resonance analysis
Rats were analyzed for EE, RQ and LA using a calorimetric system (LabMaster; TSE Systems; Bad Homburg, Germany), as previously shown (Nogueiras et al., 2007;  Martínez de Morentin et al., 2012; Imbernon et al., 2013; Martínez de Morentin et al., 2014 Contreras et al., 2014; Beiroa et al., 2014) .
Sample processing
Rats and mice were killed by cervical dislocation. From each animal, either the whole brain (for in situ hybridization) or the VMH and LHA (dissected from the whole hypothalamus for RT-PCR or western blot), as well as the BAT (for western blot) were harvested and immediately homogenized on ice to preserve phosphorylated protein levels. Samples were stored at -80ºC until further processing. Dissection of the VMH and LHA was performed by micropunches under the microscope, as previously shown (López et al., 2010; Whittle et al., 2012; Martínez de Morentin et al., 2014; Contreras et al., 2014; Beiroa et al., 2014) . The specificity of the VMH and LHA dissections was confirmed by analyzing the mRNA of steroidogenic factor-1 and prepro-orexin ( Figure   S2B ).
In situ hybridization
Coronal brain sections (16 µm) were probed with a specific oligonucleotide for prepro-OX (GenBank Accession Number: NM_013179; 5'-TTC GTA GAG ACG GCA GGA ACA CGT CTT CTG GCG ACA-3') as previously published (López et al., 2008; López et al., 2010; Whittle et al., 2012; Martínez de Morentin et al., 2012; Álvarez-Crespo et al., 2013; Martínez de Morentin et al., 2014) . Sections were scanned and the Cambridge, UK) as previously described (López et al., 2008; López et al., 2010; Whittle et al., 2012; Martínez de Morentin et al., 2012; Martínez de Morentin et al., 2014; Contreras et al., 2014; Beiroa et al., 2014) . Values were expressed in relation to α-tubulin (for BAT) or β-actin (for VMH and LHA) protein levels. We used 4-8 animals per experimental group.
Real-time PCR
We perform real-time PCR (TaqMan®; Applied Biosystems; Carlsbad, CA, USA) as previously described (López et al., 2010; Whittle et al., 2012; Martínez de Morentin et al., 2012; Martínez de Morentin et al., 2014) using specific sets of primers and probes (Table S1 ). Values were expressed relative to Hypoxanthine-guanine phosphoribosyltransferase (HPRT) levels. We used 8-9 animals per experimental group.
Immunohistochemistry
Detection of UCP1 in WAT was performed using anti-UCP1 (1:500; Abcam, Grand Island, NY, US) as previously reported (López et al., 2008; López et al., 2010; Varela et al., 2012; Whittle et al., 2012; Imbernon et al., 2013) . Images were taken with a digital camera Olympus XC50 (Olympus Corporation, Tokyo, Japan) at 20X. Digital images were quantified with ImageJ Software (National Institutes of Health, USA).
